Skeletal accumulation of fluorescently-tagged zoledronate is higher in animals with early stage chronic kidney disease

PURPOSE/INTRODUCTION: Chronic kidney disease (CKD) patients suffer from increased rates of skeletal related mortality from changes driven by biochemical abnormalities. Bisphosphonates are commonly used in reducing fracture risk in a variety of diseases yet, their use is not recommended in advanced s...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Osteoporos Int
Prif Awduron: Swallow, Elizabeth A., Aref, Mohammad W., Neal, Chen, Innocent, Byiringiro, Hammond, Max A., McCarthy, Brian P., Territo, Paul R., Kamocka, Malgorzata M., Seth, Winfree, Dunn, Kenneth W., Moe, Sharon M., Allen, Matthew R.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2018
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6103914/
https://ncbi.nlm.nih.gov/pubmed/29947866
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00198-018-4589-3
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg